These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 8774885

  • 1. Oligomerization activates c-Raf-1 through a Ras-dependent mechanism.
    Luo Z, Tzivion G, Belshaw PJ, Vavvas D, Marshall M, Avruch J.
    Nature; 1996 Sep 12; 383(6596):181-5. PubMed ID: 8774885
    [Abstract] [Full Text] [Related]

  • 2. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane.
    Leevers SJ, Paterson HF, Marshall CJ.
    Nature; 1994 Jun 02; 369(6479):411-4. PubMed ID: 8196769
    [Abstract] [Full Text] [Related]

  • 3. Activated Ras displaces 14-3-3 protein from the amino terminus of c-Raf-1.
    Rommel C, Radziwill G, Lovrić J, Noeldeke J, Heinicke T, Jones D, Aitken A, Moelling K.
    Oncogene; 1996 Feb 01; 12(3):609-19. PubMed ID: 8637718
    [Abstract] [Full Text] [Related]

  • 4. Cell signalling. Raf gets it together.
    Marshall CJ.
    Nature; 1996 Sep 12; 383(6596):127-8. PubMed ID: 8774875
    [No Abstract] [Full Text] [Related]

  • 5. Angiotensin II type 1 receptor signals through Raf-1 by a protein kinase C-dependent, Ras-independent mechanism.
    Arai H, Escobedo JA.
    Mol Pharmacol; 1996 Sep 12; 50(3):522-8. PubMed ID: 8794890
    [Abstract] [Full Text] [Related]

  • 6. Synergistic activation of c-fos promoter activity by Raf and Ral GDP dissociation stimulator.
    Okazaki M, Kishida S, Hinoi T, Hasegawa T, Tamada M, Kataoka T, Kikuchi A.
    Oncogene; 1997 Feb 06; 14(5):515-21. PubMed ID: 9053849
    [Abstract] [Full Text] [Related]

  • 7. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor.
    York RD, Yao H, Dillon T, Ellig CL, Eckert SP, McCleskey EW, Stork PJ.
    Nature; 1998 Apr 09; 392(6676):622-6. PubMed ID: 9560161
    [Abstract] [Full Text] [Related]

  • 8. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1.
    Zhang XF, Settleman J, Kyriakis JM, Takeuchi-Suzuki E, Elledge SJ, Marshall MS, Bruder JT, Rapp UR, Avruch J.
    Nature; 1993 Jul 22; 364(6435):308-13. PubMed ID: 8332187
    [Abstract] [Full Text] [Related]

  • 9. A small peptide derived from the aminoterminus of c-Raf-1 inhibits c-Raf-1/Ras binding.
    Niehof M, Radziwill G, Klauser S, Moelling K.
    Biochem Biophys Res Commun; 1995 Jan 05; 206(1):46-50. PubMed ID: 7818549
    [Abstract] [Full Text] [Related]

  • 10. Comparative effects of insulin on the activation of the Raf/Mos-dependent MAP kinase cascade in vitellogenic versus postvitellogenic Xenopus oocytes.
    Chesnel F, Bonnec G, Tardivel A, Boujard D.
    Dev Biol; 1997 Aug 01; 188(1):122-33. PubMed ID: 9245517
    [Abstract] [Full Text] [Related]

  • 11. Phosphorylation of c-Raf-1 by protein kinase A interferes with activation.
    Schramm K, Niehof M, Radziwill G, Rommel C, Moelling K.
    Biochem Biophys Res Commun; 1994 Jun 15; 201(2):740-7. PubMed ID: 8003010
    [Abstract] [Full Text] [Related]

  • 12. Identification of the sites of interaction between c-Raf-1 and Ras-GTP.
    Barnard D, Diaz B, Hettich L, Chuang E, Zhang XF, Avruch J, Marshall M.
    Oncogene; 1995 Apr 06; 10(7):1283-90. PubMed ID: 7731678
    [Abstract] [Full Text] [Related]

  • 13. Lack of evidence for the activation of the Ras/Raf mitogenic pathway by 14-3-3 proteins in mammalian cells.
    Suen KL, Bustelo XR, Barbacid M.
    Oncogene; 1995 Sep 07; 11(5):825-31. PubMed ID: 7675443
    [Abstract] [Full Text] [Related]

  • 14. Association of Grb2 with Sos and Ras with Raf-1 upon gamma irradiation of breast cancer cells.
    Suy S, Anderson WB, Dent P, Chang E, Kasid U.
    Oncogene; 1997 Jul 03; 15(1):53-61. PubMed ID: 9233777
    [Abstract] [Full Text] [Related]

  • 15. The immunophilin FKBP65 forms an association with the serine/threonine kinase c-Raf-1.
    Coss MC, Stephens RM, Morrison DK, Winterstein D, Smith LM, Simek SL.
    Cell Growth Differ; 1998 Jan 03; 9(1):41-8. PubMed ID: 9438387
    [Abstract] [Full Text] [Related]

  • 16. Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins.
    Movilla N, Crespo P, Bustelo XR.
    Oncogene; 1999 Oct 21; 18(43):5860-9. PubMed ID: 10557073
    [Abstract] [Full Text] [Related]

  • 17. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV, Reynolds ER, Shao H, Grana TM, Chan TO, Andres DA, Cox AD.
    Oncogene; 2000 Sep 28; 19(41):4685-94. PubMed ID: 11032018
    [Abstract] [Full Text] [Related]

  • 18. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro.
    Warne PH, Viciana PR, Downward J.
    Nature; 1993 Jul 22; 364(6435):352-5. PubMed ID: 8332195
    [Abstract] [Full Text] [Related]

  • 19. Effect of the activated Raf protein kinase on the human multidrug resistance 1 (MDR1) gene promoter.
    Kim SH, Lee SH, Kwak NH, Kang CD, Chung BS.
    Cancer Lett; 1996 Jan 02; 98(2):199-205. PubMed ID: 8556709
    [Abstract] [Full Text] [Related]

  • 20. Regulation of Raf-1 and Raf-1 mutants by Ras-dependent and Ras-independent mechanisms in vitro.
    Dent P, Reardon DB, Morrison DK, Sturgill TW.
    Mol Cell Biol; 1995 Aug 02; 15(8):4125-35. PubMed ID: 7623807
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.